Dear colleagues and friends,
The XXXIInd International Workshop on Helicobacter and Microbiota in Inflammation and Cancer will be held in Innsbruck, Austria, September 5 - 7, 2019.
I herewith cordially invite you to actively participate in this event.
I hope that you will have a stimulating and fruitful meeting and that you will enjoy Austria.
See you in Innsbruck in September 2019!
Prof. Dr. Herbert Tilg
President of the European Helicobacter and Microbiota Study Group
Dear colleagues and friends,
The XXXIInd International Workshop on Helicobacter and Microbiota in Inflammation and Cancer will be held in Innsbruck, Austria, September 5 - 7, 2019.
I herewith cordially invite you to actively participate in this event.
I hope that you will have a stimulating and fruitful meeting and that you will enjoy Austria.
See you in Innsbruck in September 2019!
Prof. Dr. Herbert Tilg
President of the European Helicobacter and Microbiota Study Group
XXXIInd Workshop of the European Helicobacter and Microbiota Study Group
​
September 5 - 7, 2019 | Innsbruck, Austria
PROGRAMME
Postgraduate Course
Thursday, September 5, 2019
​​“Microbiota: from metabolism to immunity and fecal microbial transplantation-pearls for the clinician”
Course directors: Antonio Gasbarrini, Herbert Tilg
Opening session:
State-of-the art lectures
Chair:
Antonio Gasbarrini, Herbert Tilg
08.00 - 09.35 hrs
08.00 - 08.05
Welcome
Herbert Tilg, Innsbruck, Austria
Antonio Gasbarrini, Rome, Italy
​
08.05 - 08.35
What is a healthy microbiome?
Julian Marchesi, London, United Kingdom
08.35 - 09.05
The gut microbiota as major player in metabolic disorders
Fredrik Bäckhed, Gothenburg, Sweden
09.05 - 09.35
Microbiota-driven personalized medicine: close to reality?
Eran Elinav, Rehovot, Israel
Coffee Break
09.35 - 10.05 hrs
The gut microbiota as complex ecosystem:
from “big data” to clinical reality
Chair: Georgina Hold, Marcis Leja
10.05 - 11.45 hrs
Inflammatory bowel disorders (IBD) and intestinal microbiota
Chair:
Patrizia Kump, Lars Engstrand
13.00 - 14.40 hrs
10.05 - 10.30
Microbiota signatures for various diseases: are we there yet?
Lars Engstrand, Stockholm, Sweden
​
10.30 - 10.55
What can be learn from population-based microbiota studies
Marie Joossens, Leuven, Belgium
​
10.55 - 11.20
Gut epithelial barrier dysfunction and evidence for a circulating microbiome
Remy Burcelin, Toulouse, France
​
11.20 - 11.45
Antibiotics: not only detrimental for the microbiota
Gianluca Ianiro, Rome, Italy
Lunch Break
11.45 - 13.00 hrs
13.00 - 13.25
Gut microbiota composition and IBD: what have we learned?
Harry Sokol, Paris, France
​
13.25 - 13.50
Pro- and prebiotics in IBD
Alessandro Armuzzi, Rome, Italy
​
13.50 - 14.15
Biomarkers associated with FMT outcomes
Nadeem Kaakoush, Syndey, Australia
​
14.15 - 14.40
Faecal microbial transplantation (FMT) and IBD
Patrizia Kump, Graz, Austria
Coffee Break
14.40 - 15.15 hrs
FMT: solution for many disorders?
Chair:
Juozas Kupcinskas, Colm O'Morain
15.15 - 16.55 hrs
15.15 - 15.40
FMT for Clostridium difficile and other antibiotics-resistant bacteria
Giovanni Cammarota, Rome, Italy
​
15.40 - 16.05
FMT for metabolic syndrome, obesity and diabetes
Max Nieuwdorp, Amsterdam, The Netherlands
​
16.05 - 16.30
FMT: a role in cancer immunotherapy?
Patricia Lepage, Jouy-en-Josas, France
​
16.30 - 16.55
FMT in chronic liver diseases and complications
Jasmohan S. Bajaj, Richmond, VA, USA
Closing
16.55 - 17.00 hrs
EHMSG Far East Symposium
Omics for Helicobacter
17.00 - 18.30 hrs
Chairs: Sang Woo Lee, Francis Mégraud, Kentaro Sugano
​
​
Dynamics of H. pylori genome and methylome variation during early and chronic infection
Sebastian Suerbaum, Munich, Germany
Current knowledge of genomics for H. pylori from Far East
Yoshio Yamaoka, Oita, Japan
Dynamics of microbial communities in the human stomach and a humanized gastric microbiota mouse model
Soon-Kyeong Kwon, Gyeongsang, South Korea